免疫原性-话题@MedSci

#免疫原性#

60篇内容 | 1196人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1393841, encodeId=45871393841da, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=J Clin Oncol：通用型癌症疫苗在晚期非小细胞肺癌中的免疫原性和疗效, objectType=article, longId=738665, objectId=219ae3866547, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=219ae3866547, replyNumber=0, likeNumber=35, createdTime=2022-09-10, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=219ae3866547, moduleTitle=J Clin Oncol：通用型癌症疫苗在晚期非小细胞肺癌中的免疫原性和疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=219ae3866547)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393840, encodeId=e3e51393840f8, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=ARD：在巴西大量自身免疫性风湿病患者中接种第三剂同源灭活SARS-CoV-2疫苗后免疫原性增加, objectType=article, longId=731834, objectId=6e88e318344a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e88e318344a, replyNumber=0, likeNumber=33, createdTime=2022-07-10, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e88e318344a, moduleTitle=ARD：在巴西大量自身免疫性风湿病患者中接种第三剂同源灭活SARS-CoV-2疫苗后免疫原性增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6e88e318344a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393839, encodeId=b272139383932, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=Diabetes Obes Metab：LY2963016甘精胰岛素和Lantus®甘精胰岛素在中国1型和2型糖尿病患者中的免疫原性, objectType=article, longId=727110, objectId=f6d9e2711026, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6d9e2711026, replyNumber=0, likeNumber=31, createdTime=2022-05-18, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6d9e2711026, moduleTitle=Diabetes Obes Metab：LY2963016甘精胰岛素和Lantus®甘精胰岛素在中国1型和2型糖尿病患者中的免疫原性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f6d9e2711026)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393838, encodeId=6dce13938381a, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=BioDrugs：AVT02 VS. 原研药阿达木单抗在中重度慢性斑块状银屑病患者中的疗效、安全性和免疫原性, objectType=article, longId=293607, objectId=125629360edc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=125629360edc, replyNumber=0, likeNumber=39, createdTime=2022-01-09, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=125629360edc, moduleTitle=BioDrugs：AVT02 VS. 原研药阿达木单抗在中重度慢性斑块状银屑病患者中的疗效、安全性和免疫原性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=125629360edc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393837, encodeId=ab5f139383eb6, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=JEADV：抗SARS-CoV-2BNT162b2疫苗在生物药物治疗银屑病中的免疫原性和安全性, objectType=article, longId=292961, objectId=bfce29296133, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bfce29296133, replyNumber=0, likeNumber=33, createdTime=2021-12-29, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bfce29296133, moduleTitle=JEADV：抗SARS-CoV-2BNT162b2疫苗在生物药物治疗银屑病中的免疫原性和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bfce29296133)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393836, encodeId=c9b1139383661, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=Lancet Respir Med：同时接种流感疫苗是否影响NVX-CoV2373疫苗的安全性与免疫原性？, objectType=article, longId=220967, objectId=dd2c22096e13, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd2c22096e13, replyNumber=0, likeNumber=34, createdTime=2021-11-26, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd2c22096e13, moduleTitle=Lancet Respir Med：同时接种流感疫苗是否影响NVX-CoV2373疫苗的安全性与免疫原性？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd2c22096e13)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393835, encodeId=7cad1393835c4, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=BJH：BNT162b2 mRNA COVID-19 疫苗在造血干细胞移植受者中的免疫原性和安全性, objectType=article, longId=219688, objectId=4a3621968844, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a3621968844, replyNumber=0, likeNumber=30, createdTime=2021-11-04, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a3621968844, moduleTitle=BJH：BNT162b2 mRNA COVID-19 疫苗在造血干细胞移植受者中的免疫原性和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4a3621968844)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393834, encodeId=3c5f1393834fc, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=Lancet Neurol：难分伯仲——非免疫原性重组葡激酶与阿尔替普酶治疗急性缺血性卒中患者的比较(FRIDA), objectType=article, longId=219166, objectId=7d30219166f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d30219166f5, replyNumber=0, likeNumber=52, createdTime=2021-10-25, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d30219166f5, moduleTitle=Lancet Neurol：难分伯仲——非免疫原性重组葡激酶与阿尔替普酶治疗急性缺血性卒中患者的比较(FRIDA), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d30219166f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393833, encodeId=7e1d13938334e, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=CID：四价人乳头瘤病毒疫苗对HIV-1感染妇女的免疫原性和安全性, objectType=article, longId=217757, objectId=89bf21e7576a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89bf21e7576a, replyNumber=0, likeNumber=36, createdTime=2021-09-28, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89bf21e7576a, moduleTitle=CID：四价人乳头瘤病毒疫苗对HIV-1感染妇女的免疫原性和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89bf21e7576a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393832, encodeId=946c139383273, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=NEJM：寨卡病毒DNA疫苗的安全性和免疫原性分析, objectType=article, longId=217207, objectId=0fc321e2076e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0fc321e2076e, replyNumber=0, likeNumber=51, createdTime=2021-09-18, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0fc321e2076e, moduleTitle=NEJM：寨卡病毒DNA疫苗的安全性和免疫原性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0fc321e2076e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393831, encodeId=ecf8139383151, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=Nat Med：PfSPZ疫苗对婴儿疟疾的安全性、免疫原性和有效性：一项双盲、随机、安慰剂对照的2期试验 , objectType=article, longId=217120, objectId=9c0421e12073, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c0421e12073, replyNumber=0, likeNumber=37, createdTime=2021-09-16, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c0421e12073, moduleTitle=Nat Med：PfSPZ疫苗对婴儿疟疾的安全性、免疫原性和有效性：一项双盲、随机、安慰剂对照的2期试验 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c0421e12073)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393830, encodeId=637b139383082, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=JNCI：癌症患者接种新冠疫苗 BNT162b2的免疫原性和安全性, objectType=article, longId=216495, objectId=7e9f21649542, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e9f21649542, replyNumber=0, likeNumber=35, createdTime=2021-09-01, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e9f21649542, moduleTitle=JNCI：癌症患者接种新冠疫苗 BNT162b2的免疫原性和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e9f21649542)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393829, encodeId=430c1393829a1, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=Nat Med：CoronaVac灭活疫苗在自身免疫性风湿病患者中的免疫原性和安全性：4期临床试验 , objectType=article, longId=215146, objectId=0b21215146d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b21215146d0, replyNumber=0, likeNumber=44, createdTime=2021-08-03, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b21215146d0, moduleTitle=Nat Med：CoronaVac灭活疫苗在自身免疫性风湿病患者中的免疫原性和安全性：4期临床试验 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b21215146d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393828, encodeId=d01013938282d, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=Nat Med：异源ChAdOx1 nCoV-19/mRNA疫苗的免疫原性和反应原性 , objectType=article, longId=214903, objectId=0209214903db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0209214903db, replyNumber=0, likeNumber=59, createdTime=2021-07-29, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0209214903db, moduleTitle=Nat Med：异源ChAdOx1 nCoV-19/mRNA疫苗的免疫原性和反应原性 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0209214903db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393827, encodeId=ef88139382e2c, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=mRNA疫苗揭密：脂质纳米颗粒的大小与免疫原性的关系, objectType=article, longId=214781, objectId=9624214e8127, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9624214e8127, replyNumber=0, likeNumber=56, createdTime=2021-07-26, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9624214e8127, moduleTitle=mRNA疫苗揭密：脂质纳米颗粒的大小与免疫原性的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9624214e8127)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393826, encodeId=e6c61393826b5, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=NEJM：BNT162b2 Covid-19疫苗在青少年中的安全性、免疫原性和有效性分析, objectType=article, longId=214260, objectId=5eb621426062, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5eb621426062, replyNumber=0, likeNumber=39, createdTime=2021-07-17, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5eb621426062, moduleTitle=NEJM：BNT162b2 Covid-19疫苗在青少年中的安全性、免疫原性和有效性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5eb621426062)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393825, encodeId=10631393825db, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=Hum Vaccin Immunother：甲肝疫苗Healive®和Havrix®在儿童中的免疫原性的持续性：11年随访观察结果, objectType=article, longId=213457, objectId=862e21345e3a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=862e21345e3a, replyNumber=0, likeNumber=40, createdTime=2021-06-30, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=862e21345e3a, moduleTitle=Hum Vaccin Immunother：甲肝疫苗Healive®和Havrix®在儿童中的免疫原性的持续性：11年随访观察结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=862e21345e3a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393824, encodeId=e582139382412, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=Lancet Infect Dis：SARS-CoV-2灭活疫苗BBIBP-CorV的安全性和免疫原性 , objectType=article, longId=213334, objectId=6a162133342f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a162133342f, replyNumber=0, likeNumber=52, createdTime=2021-06-28, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a162133342f, moduleTitle=Lancet Infect Dis：SARS-CoV-2灭活疫苗BBIBP-CorV的安全性和免疫原性 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a162133342f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393823, encodeId=86cb1393823e1, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=JAMA：COVID-19 mRNA疫苗在孕妇和哺乳期妇女中的免疫原性, objectType=article, longId=211300, objectId=3b922113006f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b922113006f, replyNumber=0, likeNumber=51, createdTime=2021-05-16, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b922113006f, moduleTitle=JAMA：COVID-19 mRNA疫苗在孕妇和哺乳期妇女中的免疫原性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b922113006f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393822, encodeId=296c139382210, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=康泰生物灭活新冠疫苗（KCONVAC）I/II期临床试验数据显示出优异的安全性和免疫原性, objectType=article, longId=209884, objectId=8e3c20988469, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e3c20988469, replyNumber=0, likeNumber=23, createdTime=2021-04-14, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e3c20988469, moduleTitle=康泰生物灭活新冠疫苗（KCONVAC）I/II期临床试验数据显示出优异的安全性和免疫原性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e3c20988469)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

免疫原性

2020-05-29

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

J Clin Oncol：通用型癌症疫苗在晚期非小细胞肺癌中的免疫原性和疗效

2022-09-10

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

ARD：在巴西大量自身免疫性风湿病患者中接种第三剂同源灭活SARS-CoV-2疫苗后免疫原性增加

2022-07-10

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

Diabetes Obes Metab：LY2963016甘精胰岛素和Lantus®甘精胰岛素在中国1型和2型糖尿病患者中的免疫原性

2022-05-18

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

BioDrugs：AVT02 VS. 原研药阿达木单抗在中重度慢性斑块状银屑病患者中的疗效、安全性和免疫原性

2022-01-09

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

JEADV：抗SARS-CoV-2BNT162b2疫苗在生物药物治疗银屑病中的免疫原性和安全性

2021-12-29

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

Lancet Respir Med：同时接种流感疫苗是否影响NVX-CoV2373疫苗的安全性与免疫原性？

2021-11-26

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

BJH：BNT162b2 mRNA COVID-19 疫苗在造血干细胞移植受者中的免疫原性和安全性

2021-11-04

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

Lancet Neurol：难分伯仲——非免疫原性重组葡激酶与阿尔替普酶治疗急性缺血性卒中患者的比较(FRIDA)

2021-10-25

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

CID：四价人乳头瘤病毒疫苗对HIV-1感染妇女的免疫原性和安全性

2021-09-28

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

NEJM：寨卡病毒DNA疫苗的安全性和免疫原性分析

2021-09-18

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

Nat Med：PfSPZ疫苗对婴儿疟疾的安全性、免疫原性和有效性：一项双盲、随机、安慰剂对照的2期试验

2021-09-16

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

JNCI：癌症患者接种新冠疫苗 BNT162b2的免疫原性和安全性

2021-09-01

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

Nat Med：CoronaVac灭活疫苗在自身免疫性风湿病患者中的免疫原性和安全性：4期临床试验

2021-08-03

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

Nat Med：异源ChAdOx1 nCoV-19/mRNA疫苗的免疫原性和反应原性

2021-07-29

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

mRNA疫苗揭密：脂质纳米颗粒的大小与免疫原性的关系

2021-07-26

一叶知秋 (审核中...)

前往app查看评论内容

#免疫原性#

NEJM：BNT162b2 Covid-19疫苗在青少年中的安全性、免疫原性和有效性分析

2021-07-17

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

Hum Vaccin Immunother：甲肝疫苗Healive®和Havrix®在儿童中的免疫原性的持续性：11年随访观察结果

2021-06-30

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

Lancet Infect Dis：SARS-CoV-2灭活疫苗BBIBP-CorV的安全性和免疫原性

2021-06-28

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

JAMA：COVID-19 mRNA疫苗在孕妇和哺乳期妇女中的免疫原性

2021-05-16

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

康泰生物灭活新冠疫苗（KCONVAC）I/II期临床试验数据显示出优异的安全性和免疫原性

2021-04-14

科室
- - 订阅+
  - 更多科室
工具
服务